Astria Therapeutics
ATXS
ATXS
28 hedge funds and large institutions have $18.4M invested in Astria Therapeutics in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding in top 10
Funds holding in top 10: →
34% less capital invested
Capital invested by funds: $28.1M → $18.4M (-$9.66M)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Holders
28
Holding in Top 10
2
Calls
$800K
Puts
–
Top Buyers
| 1 | +$249K | |
| 2 | +$116K | |
| 3 | +$79.4K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$59K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$19K |
Top Sellers
| 1 | -$1.92M | |
| 2 | -$1.56M | |
| 3 | -$1.08M | |
| 4 |
Millennium Management
New York
|
-$357K |
| 5 |
Renaissance Technologies
New York
|
-$305K |